Classical and augmentative biological control against ... - IOBC-WPRS
Classical and augmentative biological control against ... - IOBC-WPRS
Classical and augmentative biological control against ... - IOBC-WPRS
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Chapter 5<br />
Identified difficulties <strong>and</strong> conditions for field success of bio<strong>control</strong>.<br />
1. Regulatory aspects<br />
Ulf Heilig 1 , Claude Alabouvette 2* <strong>and</strong> Bernard Blum 1<br />
1 International Bio<strong>control</strong> Manufacturers Association, Blauenstrasse 57, CH-4054 Basel,<br />
Switzerl<strong>and</strong><br />
2 INRA, UMR1229, Microbiologie du Sol et de l'Environnement, 17 rue Sully, F -21000 Dijon,<br />
France<br />
Objectives<br />
The objective of the work was to identify typical hurdles for the placing of <strong>biological</strong> plant<br />
protection products on the market experienced by bio<strong>control</strong> industry or evaluators in the recent<br />
past under the European directive 91/414/EEC. In parallel, we examined the new regulation (No<br />
1107/2009/EC of the European Parliament <strong>and</strong> of the Council of 21 October 2009) concerning the<br />
placing of plant protection products on the market <strong>and</strong> repealing Council Directives 79/117/EEC<br />
<strong>and</strong> 91/414/EEC <strong>and</strong> the new directive (N° 2009/128/EC of the European Parliament <strong>and</strong> of the<br />
Council of 21 October 2009) establishing a framework for Community action to achieve the<br />
sustainable use of pesticides. These two texts were examined for provisions creating new<br />
opportunities for the approval bio<strong>control</strong> agents, their placing on the market <strong>and</strong> use. In fine, it was<br />
the intent to establish a dialogue with EU regulators <strong>and</strong> evaluators in European institutions, i.e. in<br />
the European Commission <strong>and</strong> in the European Food Safety Agency (EFSA) <strong>and</strong> to seek solutions<br />
in common for the problems encountered.<br />
Working method<br />
An ad hoc group of representatives from the bio<strong>control</strong> industry <strong>and</strong> INRA called "Regulatory<br />
Review Team" was set up. Two full-day working sessions were organised in which regulatory<br />
experts identified difficulties <strong>and</strong> questions but also described positive experience <strong>and</strong> perspectives.<br />
The work of the Regulatory Review Team active under Reasearch Activity RA4.3 of the<br />
ENDURE network was then summarised <strong>and</strong> reported in a meeting of a delegation of ENDURE<br />
partners (IBMA, INRA <strong>and</strong> ACTA) with representatives of the European Commission (DG<br />
SANCO, DG Agriculture, DG Research) <strong>and</strong> the EFSA in Brussels (24 September 2009).<br />
Results<br />
A PowerPoint presentation entitled "Gaps - Problems - Opportunities for BCAs in E.U.<br />
Regulation - From Past to Future" was prepared for the ENDURE – Commission meeting, with<br />
inputs on general regulatory issues, micro-organisms, straight chain lepidopteran pheromones <strong>and</strong><br />
botanicals. In this document, two key issues related to directive 2001/36/EC annex II B which fixed<br />
requirements for microbial active substances were highlighted. Readers may note that since 14 th<br />
June 2011 Regulation (EU) No 544/2011 implements these data requirements unchanged to reg.<br />
* Current address: AGRENE, 47 rue Constant Pierrot 21000 DIJON, c.ala@agrene.fr<br />
42